Assenagon Asset Management
RYTM icon

Assenagon Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Assenagon Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7M Buy
+186,491
New +$16.9M 0.03% 398
2025
Q4 		– Sell
-224,128
Closed -$22.6M – 1246
2025
Q3 		$22.6M Sell
224,128
-13,870
-6% -$1.29M 0.03% 345
2025
Q2 		$15M Buy
237,998
+215,806
+972% +$13.2M 0.02% 397
2025
Q1 		$1.18M Buy
+22,192
New +$1.23M ﹤0.01% 864
2024
Q4 		– Sell
-20,052
Closed -$1.05M – 1434
2024
Q3 		$1.05M Sell
20,052
-209,439
-91% -$10M ﹤0.01% 1118
2024
Q2 		$9.42M Sell
229,491
-56,160
-20% -$2.24M 0.02% 448
2024
Q1 		$12.4M Sell
285,651
-15,985
-5% -$700K 0.03% 375
2023
Q4 		$13.9M Sell
301,636
-105,654
-26% -$3.33M 0.04% 371
2023
Q3 		$9.34M Sell
407,290
-135,920
-25% -$3.04M 0.03% 401
2023
Q2 		$8.96M Sell
543,210
-120,816
-18% -$2.18M 0.03% 377
2023
Q1 		$11.8M Buy
664,026
+200,510
+43% +$5.04M 0.04% 343
2022
Q4 		$13.5M Sell
463,516
-6,894
-1% -$177K 0.05% 324
2022
Q3 		$11.5M Sell
470,410
-219,310
-32% -$4.08M 0.04% 317
2022
Q2 		$2.86M Sell
689,720
-16,200
-2% -$88.7K 0.01% 708
2022
Q1 		$8.13M Buy
705,920
+21,174
+3% +$186K 0.02% 418
2021
Q4 		$6.83M Buy
684,746
+182,476
+36% +$2.05M 0.02% 431
2021
Q3 		$6.56M Buy
502,270
+359,798
+253% +$5.49M 0.02% 359
2021
Q2 		$2.79M Buy
+142,472
New +$2.96M 0.01% 603

Other funds holding RYTM

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
EWP
Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Assenagon Asset Management's RYTM Position: Q2 2026 in Review

Assenagon Asset Management opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 186,491 shares worth $20.7M. The stake represents 0.03% of the portfolio and ranks #398 among its holdings. This is a return to the name: Assenagon Asset Management previously reported a position in RYTM as recently as Q3 2025.

Assenagon Asset Management first reported a position in RYTM in Q2 2021 and has held it in 18 quarters since. The position peaked at $22.6M in Q3 2025. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Assenagon Asset Management held 186,491 shares of Rhythm Pharmaceuticals worth $20.7M as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Assenagon Asset Management position in Q2 2026.
  • Rhythm Pharmaceuticals made up 0.03% of Assenagon Asset Management's portfolio in Q2 2026, its #398 holding.
  • Assenagon Asset Management first reported a position in Rhythm Pharmaceuticals in Q2 2021 and has held it in 18 quarters since.
  • Assenagon Asset Management's Rhythm Pharmaceuticals position peaked at $22.6M in Q3 2025.
  • 20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.